| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.0029 | 1 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.0029 | 1 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | -0.0017 | 1 |